Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-07-10 Sale | 2023-07-10 5:01 pm | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 47,702 | $0.9108 | $43,447 | 75,056 (Direct) | View |
| 2022-12-09 Sale | 2022-12-13 8:19 pm | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 31,938 | $1.0969 | $35,034 | 575,139 (Indirect Direct) | View |
| 2022-12-07 Sale | 2022-12-09 4:44 pm | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 18,425 | $1.2678 | $23,360 | 625,502 (Indirect Direct) | View |
| 2022-12-05 Sale | 2022-12-07 7:56 pm | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 23,416 | $1.3574 | $31,784 | 667,343 (Indirect Direct) | View |
| 2022-12-02 Sale | 2022-12-05 7:49 pm | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 8,408 | $1.39 | $11,687 | 519,635 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-07-01 Option Award | 2024-07-01 5:03 pm | 2025-07-01 2034-07-01 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 1,121,604 | $0 | 1,121,604 (Direct) | View |
| 2024-06-05 Option Award | 2024-06-07 4:21 pm | N/A 2034-06-04 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 7,639 | $0 | 7,639 (Direct) | View |
| 2024-06-06 Option Award | 2024-06-06 5:54 pm | N/A 2034-06-05 | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 30,550 | $0 | 30,550 (Direct) | View |
| 2023-07-05 Option Award | 2023-07-05 5:00 pm | N/A 2024-03-15 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 10,848,678 | $0 | 10,848,678 (Direct) | View |
| 2023-07-03 Option Award | 2023-07-03 5:03 pm | 2024-07-03 2033-07-03 | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 981,463 | $0 | 981,463 (Direct) | View |
| 2023-06-13 Option Award | 2023-06-15 6:25 pm | N/A 2033-06-12 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 19,441 | $0 | 19,441 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-01 4:59 pm | N/A N/A | Adaptimmune Therapeutics PLC | ADAP | Menzel Garry E Director | 611,224 | $0 | 410,578 (Indirect) | View |
| 2023-06-01 Disposition | 2023-06-01 4:22 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 1,600,413 | $0 | 0 (Direct) | View |
| 2023-05-16 Option Award | 2023-05-17 9:08 pm | N/A 2033-05-15 | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 16,500 | $0 | 16,500 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 5:32 pm | N/A 2032-12-14 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 277,689 | $0 | 682,019 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 7:49 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 442,116 | $0 | 519,635 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-18 4:56 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 262,584 | $0 | 528,043 (Direct) | View |
| 2022-11-17 Disposition | 2022-11-18 4:56 pm | N/A 2029-04-10 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 899,106 | $0 | 528,043 (Direct) | View |
| 2022-07-05 Gift | 2022-08-26 4:30 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 265,459 | $0 | 132,730 (Indirect) | View |
| 2022-06-10 Option Award | 2022-06-13 7:04 pm | N/A 2032-06-09 | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2022-06-07 Option Award | 2022-06-08 5:00 pm | N/A 2032-06-06 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 21,000 | $0 | 21,000 (Direct) | View |
| 2022-02-28 Option Award | 2022-03-18 4:24 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 1,425 | $2.3 | 265,459 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:32 pm | N/A 2031-12-08 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 305,800 | $0 | 707,865 (Direct) | View |
| 2021-08-31 Option Award | 2021-12-10 4:32 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 422 | $14.26 | 707,865 (Direct) | View |
| 2021-12-10 Exercise | 2021-12-10 4:32 pm | N/A 2026-12-12 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President & CEO | 350,000 | $0.74 | 707,865 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:01 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-18 Option Award | 2021-06-22 6:15 pm | N/A 2031-06-17 | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 15,000 | $0 | 15,000 (Direct) | View |
| 2021-04-20 Option Award | 2021-04-23 9:14 pm | N/A 2031-04-19 | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 14,921 | $0 | 14,921 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-08 08:16 am | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 686 | $16.12 | 88,612 (Direct) | View |
| 2020-08-31 Option Award | 2021-03-08 08:16 am | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 1,132 | $10.1 | 88,612 (Direct) | View |
| 2020-08-13 Option Award | 2021-01-27 5:19 pm | N/A 2030-08-13 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 29,555 | $0 | 29,555 (Direct) | View |
Ownership | 2021-01-27 5:17 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 0 | $0 | 0 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-11 06:17 am | N/A 2030-12-09 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 245,000 | $0 | 331,794 (Direct) | View |
| 2020-02-03 Conversion | 2020-02-05 5:56 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 208,122 | $0 | 51,825 (Indirect) | View |
Ownership | 2020-01-29 8:04 pm | N/A N/A | Black Diamond Therapeutics Inc. | BDTX | Menzel Garry E Director | 0 | $0 | 115,505 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-20 7:45 pm | N/A 2029-12-18 | TCR2 THERAPEUTICS INC. | TCRR | Menzel Garry E President and CEO | 168,000 | $0 | 252,527 (Direct) | View |